{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T02:02:53Z","timestamp":1771466573589,"version":"3.50.1"},"publisher-location":"New York, NY","reference-count":133,"publisher":"Springer New York","isbn-type":[{"value":"9781493933457","type":"print"},{"value":"9781493933471","type":"electronic"}],"license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016]]},"DOI":"10.1007\/978-1-4939-3347-1_9","type":"book-chapter","created":{"date-parts":[[2016,2,24]],"date-time":"2016-02-24T09:04:49Z","timestamp":1456304689000},"page":"137-162","source":"Crossref","is-referenced-by-count":30,"title":["MicroRNAs and Cancer Drug Resistance"],"prefix":"10.1007","author":[{"given":"Bruno Costa","family":"Gomes","sequence":"first","affiliation":[]},{"given":"Jos\u00e9","family":"Rueff","sequence":"additional","affiliation":[]},{"given":"Ant\u00f3nio Sebasti\u00e3o","family":"Rodrigues","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2016,2,25]]},"reference":[{"key":"9_CR1","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/0092-8674(93)90529-Y","volume":"75","author":"RC Lee","year":"1993","unstructured":"Lee RC, Feinbaum RL, Ambros V (1993) The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75:843\u2013854","journal-title":"Cell"},{"key":"9_CR2","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/35040556","volume":"408","author":"AE Pasquinelli","year":"2000","unstructured":"Pasquinelli AE, Reinhart BJ, Slack F, Martindale MQ, Kuroda MI, Maller B, Hayward DC, Ball EE, Degnan B, Muller P, Spring J, Srinivasan A, Fishman M, Finnerty J, Corbo J, Levine M, Leahy P, Davidson E, Ruvkun G (2000) Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA. Nature 408:86\u201389","journal-title":"Nature"},{"key":"9_CR3","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1126\/science.1065329","volume":"294","author":"RC Lee","year":"2001","unstructured":"Lee RC, Ambros V (2001) An extensive class of small RNAs in Caenorhabditis elegans. Science 294:862\u2013864","journal-title":"Science"},{"key":"9_CR4","doi-asserted-by":"publisher","first-page":"D68","DOI":"10.1093\/nar\/gkt1181","volume":"42","author":"A Kozomara","year":"2014","unstructured":"Kozomara A, Griffiths-Jones S (2014) miRBase: annotating high confidence microRNAs using deep sequencing data. Nucleic Acids Res 42:D68\u2013D73","journal-title":"Nucleic Acids Res"},{"key":"9_CR5","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1146\/annurev-pathol-012513-104715","volume":"9","author":"G Leva Di","year":"2014","unstructured":"Di Leva G, Garofalo M, Croce CM (2014) MicroRNAs in cancer. Annu Rev Pathol 9:287\u2013314","journal-title":"Annu Rev Pathol"},{"key":"9_CR6","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1038\/nature07299","volume":"455","author":"Y Tay","year":"2008","unstructured":"Tay Y, Zhang J, Thomson AM, Lim B, Rigoutsos I (2008) MicroRNAs to Nanog, Oct4 and Sox2 coding regions modulate embryonic stem cell differentiation. Nature 455:1124\u20131128","journal-title":"Nature"},{"issue":"22","key":"9_CR7","doi-asserted-by":"publisher","first-page":"6648","DOI":"10.1158\/0008-5472.CAN-13-3710","volume":"74","author":"L Deng","year":"2014","unstructured":"Deng L, Shang L, Bai S, Chen J, He X, Trevino RM, Chen S, Li X, Meng X, Yu B, Wang X, Liu Y, McDermott SP, Ariazi AE, Ginestier C, Ibarra I, Ke J, Luther TK, Clouthier SG, Xu L, Shan G, Song E, Yao H, Hannon GJ, Weiss SJ, Wicha MS, Liu S (2014) MicroRNA100 inhibits self-renewal of breast cancer stem-like cells and breast tumor development. Cancer Res 74(22):6648\u20136660","journal-title":"Cancer Res"},{"key":"9_CR8","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1002\/jcp.24822","volume":"230","author":"IH Kang","year":"2014","unstructured":"Kang IH, Jeong BC, Hur SW, Choi H, Choi SH, Ryu JH, Hwang YC, Koh JT (2014) MicroRNA-302a stimulates osteoblastic differentiation by repressing COUP-TFII expression. J Cell Physiol 230:911\u2013921","journal-title":"J Cell Physiol"},{"issue":"2","key":"9_CR9","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.yexcr.2014.08.033","volume":"329","author":"SS Lazare","year":"2014","unstructured":"Lazare SS, Wojtowicz EE, Bystrykh LV, de Haan G (2014) microRNAs in hematopoiesis. Exp Cell Res 329(2):234\u2013238","journal-title":"Exp Cell Res"},{"key":"9_CR10","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.gene.2014.09.052","volume":"552","author":"M Janaki Ramaiah","year":"2014","unstructured":"Janaki Ramaiah M, Lavanya A, Honarpisheh M, Zarea M, Bhadra U, Bhadra MP (2014) miR-15\/16 complex targets p70S6 kinase1 and controls cell proliferation in MDA-MB-231 breast cancer cells. Gene 552:255\u2013264","journal-title":"Gene"},{"key":"9_CR11","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1186\/1471-2407-14-703","volume":"14","author":"K Zhong","year":"2014","unstructured":"Zhong K, Chen K, Han L, Li B (2014) microRNA-30b\/c inhibits non-small cell lung cancer cell proliferation by targeting Rab18. BMC Cancer 14:703","journal-title":"BMC Cancer"},{"key":"9_CR12","doi-asserted-by":"publisher","first-page":"2172","DOI":"10.4161\/cc.10.13.16248","volume":"10","author":"M Lerner","year":"2011","unstructured":"Lerner M, Lundgren J, Akhoondi S, Jahn A, Ng HF, Akbari Moqadam F, Oude Vrielink JA, Agami R, Den Boer ML, Grander D, Sangfelt O (2011) MiRNA-27a controls FBW7\/hCDC4-dependent cyclin E degradation and cell cycle progression. Cell Cycle 10:2172\u20132183","journal-title":"Cell Cycle"},{"key":"9_CR13","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1038\/aps.2011.103","volume":"32","author":"LH Liang","year":"2011","unstructured":"Liang LH, He XH (2011) Macro-management of microRNAs in cell cycle progression of tumor cells and its implications in anti-cancer therapy. Acta Pharmacol Sin 32:1311\u20131320","journal-title":"Acta Pharmacol Sin"},{"key":"9_CR14","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.3892\/or.2014.3374","volume":"32","author":"L Zhou","year":"2014","unstructured":"Zhou L, Zhang WG, Wang DS, Tao KS, Song WJ, Dou KF (2014) MicroRNA-183 is involved in cell proliferation, survival and poor prognosis in pancreatic ductal adenocarcinoma by regulating Bmi-1. Oncol Rep 32:1734\u20131740","journal-title":"Oncol Rep"},{"key":"9_CR15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0096239","volume":"9","author":"DH Floyd","year":"2014","unstructured":"Floyd DH, Zhang Y, Dey BK, Kefas B, Breit H, Marks K, Dutta A, Herold-Mende C, Synowitz M, Glass R, Abounader R, Purow BW (2014) Novel anti-apoptotic microRNAs 582-5p and 363 promote human glioblastoma stem cell survival via direct inhibition of caspase 3, caspase 9, and Bim. PLoS One 9, e96239","journal-title":"PLoS One"},{"key":"9_CR16","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s11010-014-2164-6","volume":"396","author":"R Li","year":"2014","unstructured":"Li R, Yuan W, Mei W, Yang K, Chen Z (2014) MicroRNA 520d-3p inhibits gastric cancer cell proliferation, migration, and invasion by downregulating EphA2 expression. Mol Cell Biochem 396:295\u2013305","journal-title":"Mol Cell Biochem"},{"issue":"11","key":"9_CR17","doi-asserted-by":"publisher","first-page":"10897","DOI":"10.1007\/s13277-014-2402-2","volume":"35","author":"W Li","year":"2014","unstructured":"Li W, Zang W, Liu P, Wang Y, Du Y, Chen X, Deng M, Sun W, Wang L, Zhao G, Zhai B (2014) MicroRNA-124 inhibits cellular proliferation and invasion by targeting Ets-1 in breast cancer. Tumour Biol 35(11):10897\u201310904","journal-title":"Tumour Biol"},{"issue":"1","key":"9_CR18","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s11060-014-1607-y","volume":"121","author":"R Zhang","year":"2014","unstructured":"Zhang R, Luo H, Wang S, Chen Z, Hua L, Wang HW, Chen W, Yuan Y, Zhou X, Li D, Shen S, Jiang T, You Y, Liu N, Wang H (2014) miR-622 suppresses proliferation, invasion and migration by directly targeting activating transcription factor 2 in glioma cells. J Neurooncol 121(1):63\u201372","journal-title":"J Neurooncol"},{"key":"9_CR19","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1016\/j.febslet.2010.08.009","volume":"585","author":"SA Melo","year":"2011","unstructured":"Melo SA, Esteller M (2011) Dysregulation of microRNAs in cancer: playing with fire. FEBS Lett 585:2087\u20132099","journal-title":"FEBS Lett"},{"key":"9_CR20","doi-asserted-by":"publisher","first-page":"2999","DOI":"10.1073\/pnas.0307323101","volume":"101","author":"G Calin","year":"2004","unstructured":"Calin G, Sevignani C, Dumitru C, Hyslop T, Noch E, Yendamuri S, Shimizu M, Rattan S, Bullrich F, Negrini M (2004) Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci U S A 101:2999\u20133004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9_CR21","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/s10555-009-9188-5","volume":"28","author":"SK Shenouda","year":"2009","unstructured":"Shenouda SK, Alahari SK (2009) MicroRNA function in cancer: oncogene or a tumor suppressor? Cancer Metastasis Rev 28:369\u2013378","journal-title":"Cancer Metastasis Rev"},{"key":"9_CR22","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.jmoldx.2012.01.016","volume":"14","author":"M Raychaudhuri","year":"2012","unstructured":"Raychaudhuri M, Schuster T, Buchner T, Malinowsky K, Bronger H, Schwarz-Boeger U, Hofler H, Avril S (2012) Intratumoral heterogeneity of microRNA expression in breast cancer. J Mol Diagn 14:376\u2013384","journal-title":"J Mol Diagn"},{"key":"9_CR23","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.3390\/cancers6031769","volume":"6","author":"G Housman","year":"2014","unstructured":"Housman G, Byler S, Heerboth S, Lapinska K, Longacre M, Snyder N, Sarkar S (2014) Drug resistance in cancer: an overview. Cancers 6:1769\u20131792","journal-title":"Cancers"},{"key":"9_CR24","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1038\/nrc3599","volume":"13","author":"C Holohan","year":"2013","unstructured":"Holohan C, Van Schaeybroeck S, Longley DB, Johnston PG (2013) Cancer drug resistance: an evolving paradigm. Nat Rev Cancer 13:714\u2013726","journal-title":"Nat Rev Cancer"},{"key":"9_CR25","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1002\/path.1706","volume":"205","author":"DB Longley","year":"2005","unstructured":"Longley DB, Johnston PG (2005) Molecular mechanisms of drug resistance. J Pathol 205:275\u2013292","journal-title":"J Pathol"},{"key":"9_CR26","doi-asserted-by":"publisher","first-page":"651","DOI":"10.2174\/138920112799857549","volume":"13","author":"AS Rodrigues","year":"2012","unstructured":"Rodrigues AS, Dinis J, Gromicho M, Martins C, Laires A, Rueff J (2012) Genomics and cancer drug resistance. Curr Pharm Biotechnol 13:651\u2013673","journal-title":"Curr Pharm Biotechnol"},{"key":"9_CR27","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.molmed.2011.04.003","volume":"17","author":"JL Rukov","year":"2011","unstructured":"Rukov JL, Shomron N (2011) MicroRNA pharmacogenomics: post-transcriptional regulation of drug response. Trends Mol Med 17:412\u2013423","journal-title":"Trends Mol Med"},{"key":"9_CR28","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1089\/omi.2013.0098","volume":"18","author":"M Manikandan","year":"2014","unstructured":"Manikandan M, Munirajan AK (2014) Single nucleotide polymorphisms in microRNA binding sites of oncogenes: implications in cancer and pharmacogenomics. Omics 18:142\u2013154","journal-title":"Omics"},{"key":"9_CR29","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1177\/0091270007299930","volume":"47","author":"BL Urquhart","year":"2007","unstructured":"Urquhart BL, Tirona RG, Kim RB (2007) Nuclear receptors and the regulation of drug-metabolizing enzymes and drug transporters: implications for interindividual variability in response to drugs. J Clin Pharmacol 47:566\u2013578","journal-title":"J Clin Pharmacol"},{"key":"9_CR30","doi-asserted-by":"publisher","first-page":"9090","DOI":"10.1158\/0008-5472.CAN-06-1403","volume":"66","author":"Y Tsuchiya","year":"2006","unstructured":"Tsuchiya Y, Nakajima M, Takagi S, Taniya T, Yokoi T (2006) MicroRNA regulates the expression of human cytochrome P450 1B1. Cancer Res 66:9090\u20139098","journal-title":"Cancer Res"},{"key":"9_CR31","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.pharmthera.2014.03.002","volume":"143","author":"K Ikemura","year":"2014","unstructured":"Ikemura K, Iwamoto T, Okuda M (2014) MicroRNAs as regulators of drug transporters, drug-metabolizing enzymes, and tight junctions: implication for intestinal barrier function. Pharmacol Ther 143:217\u2013224","journal-title":"Pharmacol Ther"},{"key":"9_CR32","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1517\/17425255.2012.673587","volume":"8","author":"I Koturbash","year":"2012","unstructured":"Koturbash I, Beland FA, Pogribny IP (2012) Role of microRNAs in the regulation of drug metabolizing and transporting genes and the response to environmental toxicants. Expert Opin Drug Metab Toxicol 8:597\u2013606","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"9_CR33","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1038\/sj.onc.1209377","volume":"25","author":"C Rodriguez-Antona","year":"2006","unstructured":"Rodriguez-Antona C, Ingelman-Sundberg M (2006) Cytochrome P450 pharmacogenetics and cancer. Oncogene 25:1679\u20131691","journal-title":"Oncogene"},{"issue":"1","key":"9_CR34","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1021\/tx500444e","volume":"28","author":"SP Rendic","year":"2015","unstructured":"Rendic SP, Guengerich FP (2015) Survey of human oxidoreductases and cytochrome P450 enzymes involved in the metabolism of chemicals. Chem Res Toxicol 28(1):38\u201342","journal-title":"Chem Res Toxicol"},{"key":"9_CR35","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1124\/dmd.30.8.869","volume":"30","author":"HK Crewe","year":"2002","unstructured":"Crewe HK, Notley LM, Wunsch RM, Lennard MS, Gillam EM (2002) Metabolism of tamoxifen by recombinant human cytochrome P450 enzymes: formation of the 4-hydroxy, 4\u2032-hydroxy and N-desmethyl metabolites and isomerization of trans-4-hydroxytamoxifen. Drug Metab Dispos 30:869\u2013874","journal-title":"Drug Metab Dispos"},{"key":"9_CR36","doi-asserted-by":"publisher","first-page":"R107","DOI":"10.1186\/bcr3574","volume":"15","author":"T Leung","year":"2013","unstructured":"Leung T, Rajendran R, Singh S, Garva R, Krstic-Demonacos M, Demonacos C (2013) Cytochrome P450 2E1 (CYP2E1) regulates the response to oxidative stress and migration of breast cancer cells. Breast Cancer Res 15:R107","journal-title":"Breast Cancer Res"},{"key":"9_CR37","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/j.bcp.2009.11.015","volume":"79","author":"T Mohri","year":"2010","unstructured":"Mohri T, Nakajima M, Fukami T, Takamiya M, Aoki Y, Yokoi T (2010) Human CYP2E1 is regulated by miR-378. Biochem Pharmacol 79:1045\u20131052","journal-title":"Biochem Pharmacol"},{"key":"9_CR38","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.1124\/dmd.109.027680","volume":"37","author":"YZ Pan","year":"2009","unstructured":"Pan YZ, Gao W, Yu AM (2009) MicroRNAs regulate CYP3A4 expression via direct and indirect targeting. Drug Metab Dispos 37:2112\u20132117","journal-title":"Drug Metab Dispos"},{"key":"9_CR39","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1081\/DMR-120001394","volume":"33","author":"MW Duffel","year":"2001","unstructured":"Duffel MW, Marshal AD, McPhie P, Sharma V, Jakoby WB (2001) Enzymatic aspects of the phenol (aryl) sulfotransferases. Drug Metab Rev 33:369\u2013395","journal-title":"Drug Metab Rev"},{"key":"9_CR40","first-page":"92","volume":"1","author":"KE Mercer","year":"2010","unstructured":"Mercer KE, Apostolov EO, da Costa GG, Yu X, Lang P, Roberts DW, Davis W, Basnakian AG, Kadlubar FF, Kadlubar SA (2010) Expression of sulfotransferase isoform 1A1 (SULT1A1) in breast cancer cells significantly increases 4-hydroxytamoxifen-induced apoptosis. Int J Mol Epidemiol Genet 1:92\u2013103","journal-title":"Int J Mol Epidemiol Genet"},{"key":"9_CR41","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1093\/toxsci\/kfq296","volume":"118","author":"X Yu","year":"2010","unstructured":"Yu X, Dhakal IB, Beggs M, Edavana VK, Williams S, Zhang X, Mercer K, Ning B, Lang NP, Kadlubar FF, Kadlubar S (2010) Functional genetic variants in the 3\u2032-untranslated region of sulfotransferase isoform 1A1 (SULT1A1) and their effect on enzymatic activity. Toxicol Sci 118:391\u2013403","journal-title":"Toxicol Sci"},{"key":"9_CR42","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/jhg.2011.126","volume":"57","author":"Y Moriya","year":"2012","unstructured":"Moriya Y, Nohata N, Kinoshita T, Mutallip M, Okamoto T, Yoshida S, Suzuki M, Yoshino I, Seki N (2012) Tumor suppressive microRNA-133a regulates novel molecular networks in lung squamous cell carcinoma. J Hum Genet 57:38\u201345","journal-title":"J Hum Genet"},{"key":"9_CR43","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1054\/drup.1999.0083","volume":"2","author":"LI McLellan","year":"1999","unstructured":"McLellan LI, Wolf CR (1999) Glutathione and glutathione-dependent enzymes in cancer drug resistance. Drug Resist Updat 2:153\u2013164","journal-title":"Drug Resist Updat"},{"key":"9_CR44","first-page":"527","volume":"48","author":"TC Shea","year":"1988","unstructured":"Shea TC, Kelley SL, Henner WD (1988) Identification of an anionic form of glutathione transferase present in many human tumors and human tumor cell lines. Cancer Res 48:527\u2013533","journal-title":"Cancer Res"},{"key":"9_CR45","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1038\/bjc.2014.386","volume":"111","author":"L Sawers","year":"2014","unstructured":"Sawers L, Ferguson MJ, Ihrig BR, Young HC, Chakravarty P, Wolf CR, Smith G (2014) Glutathione S-transferase P1 (GSTP1) directly influences platinum drug chemosensitivity in ovarian tumour cell lines. Br J Cancer 111:1150\u20131158","journal-title":"Br J Cancer"},{"key":"9_CR46","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/nrc706","volume":"2","author":"MM Gottesman","year":"2002","unstructured":"Gottesman MM, Fojo T, Bates SE (2002) Multidrug resistance in cancer: role of ATP-dependent transporters. Nat Rev Cancer 2:48\u201358","journal-title":"Nat Rev Cancer"},{"key":"9_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.drup.2014.11.002","volume":"18","author":"RJ Kathawala","year":"2014","unstructured":"Kathawala RJ, Gupta P, Ashby CR Jr, Chen Z (2014) The modulation of ABC transporter-mediated multidrug resistance in cancer: a review of the past decade. Drug Resist Updat 18:1\u201317","journal-title":"Drug Resist Updat"},{"key":"9_CR48","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/S0022-2275(20)31588-1","volume":"42","author":"M Dean","year":"2001","unstructured":"Dean M, Hamon Y, Chimini G (2001) The human ATP-binding cassette (ABC) transporter superfamily. J Lipid Res 42:1007\u20131017","journal-title":"J Lipid Res"},{"key":"9_CR49","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1111\/bcp.12251","volume":"77","author":"S Haenisch","year":"2014","unstructured":"Haenisch S, Werk AN, Cascorbi I (2014) MicroRNAs and their relevance to ABC transporters. Br J Clin Pharmacol 77:587\u2013596","journal-title":"Br J Clin Pharmacol"},{"key":"9_CR50","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.3109\/10428194.2011.584005","volume":"52","author":"M Gromicho","year":"2011","unstructured":"Gromicho M, Dinis J, Magalh\u00e3es M, Fernandes A, Tavares P, Laires A, Rueff J, Rodrigues A (2011) Development of Imatinib and Dasatinib resistance: dynamics of the drug transporters expression ABCB1, ABCC1, ABCG2, MVP and SLC22A1. Leuk Lymphoma 52:1980\u20131990","journal-title":"Leuk Lymphoma"},{"key":"9_CR51","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1158\/1535-7163.MCT-08-0021","volume":"7","author":"O Kovalchuk","year":"2008","unstructured":"Kovalchuk O, Filkowski J, Meservy J, Ilnytskyy Y, Tryndyak VP, Chekhun VF, Pogribny IP (2008) Involvement of microRNA-451 in resistance of the MCF-7 breast cancer cells to chemotherapeutic drug doxorubicin. Mol Cancer Ther 7:2152\u20132159","journal-title":"Mol Cancer Ther"},{"key":"9_CR52","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.1007\/s12032-011-0117-4","volume":"29","author":"J Chen","year":"2012","unstructured":"Chen J, Tian W, Cai H, He H, Deng Y (2012) Down-regulation of microRNA-200c is associated with drug resistance in human breast cancer. Med Oncol 29:2527\u20132534","journal-title":"Med Oncol"},{"key":"9_CR53","doi-asserted-by":"publisher","first-page":"2490","DOI":"10.1016\/j.ajpath.2012.02.024","volume":"180","author":"L Bao","year":"2012","unstructured":"Bao L, Hazari S, Mehra S, Kaushal D, Moroz K, Dash S (2012) Increased expression of P-glycoprotein and doxorubicin chemoresistance of metastatic breast cancer is regulated by miR-298. Am J Pathol 180:2490\u20132503","journal-title":"Am J Pathol"},{"key":"9_CR54","doi-asserted-by":"crossref","first-page":"741","DOI":"10.3892\/or.2012.2153","volume":"29","author":"M Gromicho","year":"2013","unstructured":"Gromicho M, Magalhaes M, Torres F, Dinis J, Fernandes AR, Rendeiro P, Tavares P, Laires A, Rueff J, Sebastiao Rodrigues A (2013) Instability of mRNA expression signatures of drug transporters in chronic myeloid leukemia patients resistant to imatinib. Oncol Rep 29:741\u2013750","journal-title":"Oncol Rep"},{"key":"9_CR55","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1016\/j.biocel.2010.01.014","volume":"42","author":"MT Jaarsveld van","year":"2010","unstructured":"van Jaarsveld MT, Helleman J, Berns EM, Wiemer EA (2010) MicroRNAs in ovarian cancer biology and therapy resistance. Int J Biochem Cell Biol 42:1282\u20131290","journal-title":"Int J Biochem Cell Biol"},{"key":"9_CR56","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/j.bcp.2008.06.007","volume":"76","author":"H Zhu","year":"2008","unstructured":"Zhu H, Wu H, Liu X, Evans BR, Medina DJ, Liu CG, Yang JM (2008) Role of MicroRNA miR-27a and miR-451 in the regulation of MDR1\/P-glycoprotein expression in human cancer cells. Biochem Pharmacol 76:582\u2013588","journal-title":"Biochem Pharmacol"},{"key":"9_CR57","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1124\/mol.112.081844","volume":"83","author":"K Ikemura","year":"2013","unstructured":"Ikemura K, Yamamoto M, Miyazaki S, Mizutani H, Iwamoto T, Okuda M (2013) MicroRNA-145 post-transcriptionally regulates the expression and function of P-glycoprotein in intestinal epithelial cells. Mol Pharmacol 83:399\u2013405","journal-title":"Mol Pharmacol"},{"key":"9_CR58","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0082062","volume":"8","author":"Y Xu","year":"2013","unstructured":"Xu Y, Ohms SJ, Li Z, Wang Q, Gong G, Hu Y, Mao Z, Shannon MF, Fan JY (2013) Changes in the expression of miR-381 and miR-495 are inversely associated with the expression of the MDR1 gene and development of multi-drug resistance. PLoS One 8, e82062","journal-title":"PLoS One"},{"key":"9_CR59","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1016\/j.bcp.2012.01.002","volume":"83","author":"K Natarajan","year":"2012","unstructured":"Natarajan K, Xie Y, Baer MR, Ross DD (2012) Role of breast cancer resistance protein (BCRP\/ABCG2) in cancer drug resistance. Biochem Pharmacol 83:1084\u20131103","journal-title":"Biochem Pharmacol"},{"key":"9_CR60","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1002\/ijc.11528","volume":"108","author":"K Shiozawa","year":"2004","unstructured":"Shiozawa K, Oka M, Soda H, Yoshikawa M, Ikegami Y, Tsurutani J, Nakatomi K, Nakamura Y, Doi S, Kitazaki T, Mizuta Y, Murase K, Yoshida H, Ross DD, Kohno S (2004) Reversal of breast cancer resistance protein (BCRP\/ABCG2)-mediated drug resistance by novobiocin, a coumermycin antibiotic. Int J Cancer 108:146\u2013151","journal-title":"Int J Cancer"},{"key":"9_CR61","doi-asserted-by":"publisher","first-page":"6510","DOI":"10.1158\/1078-0432.CCR-11-1403","volume":"17","author":"J Selever","year":"2011","unstructured":"Selever J, Gu G, Lewis MT, Beyer A, Herynk MH, Covington KR, Tsimelzon A, Dontu G, Provost P, Di Pietro A, Boumendjel A, Albain K, Miele L, Weiss H, Barone I, Ando S, Fuqua SA (2011) Dicer-mediated upregulation of BCRP confers tamoxifen resistance in human breast cancer cells. Clin Cancer Res 17:6510\u20136521","journal-title":"Clin Cancer Res"},{"key":"9_CR62","first-page":"827","volume":"9","author":"H Burger","year":"2003","unstructured":"Burger H, Foekens JA, Look MP, Meijer-van Gelder ME, Klijn JG, Wiemer EA, Stoter G, Nooter K (2003) RNA expression of breast cancer resistance protein, lung resistance-related protein, multidrug resistance-associated proteins 1 and 2, and multidrug resistance gene 1 in breast cancer: correlation with chemotherapeutic response. Clin Cancer Res 9:827\u2013836","journal-title":"Clin Cancer Res"},{"key":"9_CR63","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1007\/s10549-013-2607-x","volume":"139","author":"X Jiao","year":"2013","unstructured":"Jiao X, Zhao L, Ma M, Bai X, He M, Yan Y, Wang Y, Chen Q, Zhao X, Zhou M, Cui Z, Zheng Z, Wang E, Wei M (2013) MiR-181a enhances drug sensitivity in mitoxantone-resistant breast cancer cells by targeting breast cancer resistance protein (BCRP\/ABCG2). Breast Cancer Res Treat 139:717\u2013730","journal-title":"Breast Cancer Res Treat"},{"key":"9_CR64","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1124\/mol.108.054163","volume":"75","author":"YZ Pan","year":"2009","unstructured":"Pan YZ, Morris ME, Yu AM (2009) MicroRNA-328 negatively regulates the expression of breast cancer resistance protein (BCRP\/ABCG2) in human cancer cells. Mol Pharmacol 75:1374\u20131379","journal-title":"Mol Pharmacol"},{"key":"9_CR65","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.canlet.2013.07.016","volume":"339","author":"MT Ma","year":"2013","unstructured":"Ma MT, He M, Wang Y, Jiao XY, Zhao L, Bai XF, Yu ZJ, Wu HZ, Sun ML, Song ZG, Wei MJ (2013) MiR-487a resensitizes mitoxantrone (MX)-resistant breast cancer cells (MCF-7\/MX) to MX by targeting breast cancer resistance protein (BCRP\/ABCG2). Cancer Lett 339:107\u2013115","journal-title":"Cancer Lett"},{"key":"9_CR66","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.bcp.2010.12.018","volume":"81","author":"X Li","year":"2011","unstructured":"Li X, Pan YZ, Seigel GM, Hu ZH, Huang M, Yu AM (2011) Breast cancer resistance protein BCRP\/ABCG2 regulatory microRNAs (hsa-miR-328, -519c and -520h) and their differential expression in stem-like ABCG2+ cancer cells. Biochem Pharmacol 81:783\u2013792","journal-title":"Biochem Pharmacol"},{"key":"9_CR67","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1146\/annurev-pharmtox-011613-135959","volume":"54","author":"SP Cole","year":"2014","unstructured":"Cole SP (2014) Targeting multidrug resistance protein 1 (MRP1, ABCC1): past, present, and future. Annu Rev Pharmacol Toxicol 54:95\u2013117","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"9_CR68","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1002\/ijc.25191","volume":"127","author":"IP Pogribny","year":"2010","unstructured":"Pogribny IP, Filkowski JN, Tryndyak VP, Golubov A, Shpyleva SI, Kovalchuk O (2010) Alterations of microRNAs and their targets are associated with acquired resistance of MCF-7 breast cancer cells to cisplatin. Int J Cancer 127:1785\u20131794","journal-title":"Int J Cancer"},{"key":"9_CR69","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/j.bcp.2009.10.017","volume":"79","author":"Z Liang","year":"2010","unstructured":"Liang Z, Wu H, Xia J, Li Y, Zhang Y, Huang K, Wagar N, Yoon Y, Cho HT, Scala S, Shim H (2010) Involvement of miR-326 in chemotherapy resistance of breast cancer through modulating expression of multidrug resistance-associated protein 1. Biochem Pharmacol 79:817\u2013824","journal-title":"Biochem Pharmacol"},{"key":"9_CR70","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1124\/dmd.113.052092","volume":"41","author":"YZ Pan","year":"2013","unstructured":"Pan YZ, Zhou A, Hu Z, Yu AM (2013) Small nucleolar RNA-derived microRNA hsa-miR-1291 modulates cellular drug disposition through direct targeting of ABC transporter ABCC1. Drug Metab Dispos 41:1744\u20131751","journal-title":"Drug Metab Dispos"},{"key":"9_CR71","doi-asserted-by":"publisher","first-page":"3226","DOI":"10.1111\/j.1742-4658.2011.08235.x","volume":"278","author":"ZS Chen","year":"2011","unstructured":"Chen ZS, Tiwari AK (2011) Multidrug resistance proteins (MRPs\/ABCCs) in cancer chemotherapy and genetic diseases. FEBS J 278:3226\u20133245","journal-title":"FEBS J"},{"key":"9_CR72","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1042\/BJ20120386","volume":"446","author":"K Xu","year":"2012","unstructured":"Xu K, Liang X, Shen K, Cui D, Zheng Y, Xu J, Fan Z, Qiu Y, Li Q, Ni L, Liu J (2012) miR-297 modulates multidrug resistance in human colorectal carcinoma by down-regulating MRP-2. Biochem J 446:291\u2013300","journal-title":"Biochem J"},{"key":"9_CR73","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1053\/j.gastro.2010.07.040","volume":"139","author":"LB McKenna","year":"2010","unstructured":"McKenna LB, Schug J, Vourekas A, McKenna JB, Bramswig NC, Friedman JR, Kaestner KH (2010) MicroRNAs control intestinal epithelial differentiation, architecture, and barrier function. Gastroenterology 139:1654\u20131664, 1664\u20131651","journal-title":"Gastroenterology"},{"key":"9_CR74","doi-asserted-by":"publisher","first-page":"G52","DOI":"10.1152\/ajpgi.00394.2010","volume":"300","author":"G Dalmasso","year":"2011","unstructured":"Dalmasso G, Nguyen HT, Yan Y, Laroui H, Charania MA, Obertone TS, Sitaraman SV, Merlin D (2011) MicroRNA-92b regulates expression of the oligopeptide transporter PepT1 in intestinal epithelial cells. Am J Physiol Gastrointest Liver Physiol 300:G52\u2013G59","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"9_CR75","doi-asserted-by":"publisher","first-page":"3182","DOI":"10.1128\/MCB.01433-10","volume":"31","author":"TJ Pullen","year":"2011","unstructured":"Pullen TJ, da Silva Xavier G, Kelsey G, Rutter GA (2011) miR-29a and miR-29b contribute to pancreatic beta-cell-specific silencing of monocarboxylate transporter 1 (Mct1). Mol Cell Biol 31:3182\u20133194","journal-title":"Mol Cell Biol"},{"key":"9_CR76","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1038\/nature08467","volume":"461","author":"SP Jackson","year":"2009","unstructured":"Jackson SP, Bartek J (2009) The DNA-damage response in human biology and disease. Nature 461:1071\u20131078","journal-title":"Nature"},{"key":"9_CR77","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.molcel.2007.11.015","volume":"28","author":"JW Harper","year":"2007","unstructured":"Harper JW, Elledge SJ (2007) The DNA damage response: ten years after. Mol Cell 28:739\u2013745","journal-title":"Mol Cell"},{"key":"9_CR78","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1038\/nrc3891","volume":"15","author":"LH Pearl","year":"2015","unstructured":"Pearl LH, Schierz AC, Ward SE, Al-Lazikani B, Pearl FMG (2015) Therapeutic opportunities within the DNA damage response. Nat Rev Cancer 15:166\u2013180","journal-title":"Nat Rev Cancer"},{"key":"9_CR79","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/nrc2440","volume":"8","author":"F d'Adda di Fagagna","year":"2008","unstructured":"d'Adda di Fagagna F (2008) Living on a break: cellular senescence as a DNA-damage response. Nat Rev Cancer 8:512\u2013522","journal-title":"Nat Rev Cancer"},{"key":"9_CR80","doi-asserted-by":"publisher","first-page":"417","DOI":"10.2174\/187152008784220294","volume":"8","author":"MR Kelley","year":"2008","unstructured":"Kelley MR, Fishel ML (2008) DNA repair proteins as molecular targets for cancer therapeutics. Anticancer Agents Med Chem 8:417\u2013425","journal-title":"Anticancer Agents Med Chem"},{"key":"9_CR81","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1016\/j.dnarep.2011.09.003","volume":"10","author":"MR Kelley","year":"2011","unstructured":"Kelley MR (2011) DNA repair inhibitors: where do we go from here? DNA Repair (Amst) 10:1183\u20131185","journal-title":"DNA Repair (Amst)"},{"key":"9_CR82","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/B978-0-12-384999-1.10014-9","volume-title":"DNA repair in cancer therapy","author":"MR Kelley","year":"2012","unstructured":"Kelley MR (2012) Future directions with DNA repair inhibitors: a roadmap for disruptive approaches to cancer therapy (Chapter 14). In: Mark RK (ed) DNA repair in cancer therapy. Academic, San Diego, CA, pp 301\u2013310. doi: 10.1016\/b978-0-12-384999-1.10014-9"},{"key":"9_CR83","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/nrc2342","volume":"8","author":"T Helleday","year":"2008","unstructured":"Helleday T, Petermann E, Lundin C, Hodgson B, Sharma RA (2008) DNA repair pathways as targets for cancer therapy. Nat Rev Cancer 8:193\u2013204","journal-title":"Nat Rev Cancer"},{"key":"9_CR84","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.3109\/10428194.2012.681654","volume":"53","author":"J Dinis","year":"2012","unstructured":"Dinis J, Silva V, Gromicho M, Martins C, Laires A, Tavares P, Rendeiro P, Torres F, Rueff J, Rodrigues A (2012) DNA damage response in imatinib resistant chronic myeloid leukemia K562 cells. Leuk Lymphoma 53:2004\u20132014","journal-title":"Leuk Lymphoma"},{"key":"9_CR85","volume-title":"New Research Directions in DNA Repair","author":"Antnio S.","year":"2013","unstructured":"Rodrigues AS, Gomes BC, Martins C, Gromicho M, Oliveira NG, Guerreiro PS, Rueff J (2013) DNA repair and resistance to cancer therapy. In: Chen C (ed) DNA repair and resistance to cancer therapy, new research directions in DNA repair. Intech. doi:10.5772\/53952"},{"key":"9_CR86","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1038\/35077232","volume":"411","author":"J Hoeijmakers","year":"2001","unstructured":"Hoeijmakers J (2001) Genome maintenance mechanisms for preventing cancer. Nature 411:366\u2013374","journal-title":"Nature"},{"key":"9_CR87","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1056\/NEJMra0804615","volume":"361","author":"JH Hoeijmakers","year":"2009","unstructured":"Hoeijmakers JH (2009) DNA damage, aging, and cancer. N Engl J Med 361:1475\u20131485","journal-title":"N Engl J Med"},{"key":"9_CR88","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1016\/j.febslet.2013.05.006","volume":"587","author":"V Sharma","year":"2013","unstructured":"Sharma V, Misteli T (2013) Non-coding RNAs in DNA damage and repair. FEBS Lett 587:1832\u20131839","journal-title":"FEBS Lett"},{"key":"9_CR89","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.ijrobp.2010.12.061","volume":"80","author":"T Templin","year":"2011","unstructured":"Templin T, Paul S, Amundson SA, Young EF, Barker CA, Wolden SL, Smilenov LB (2011) Radiation-induced micro-RNA expression changes in peripheral blood cells of radiotherapy patients. Int J Radiat Oncol Biol Phys 80:549\u2013557","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"9_CR90","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.1038\/emboj.2009.156","volume":"28","author":"J Pothof","year":"2009","unstructured":"Pothof J, Verkaik NS, Van IW, Ta VT, van der Horst GT, Jaspers NG, van Gent DC, Hoeijmakers JH, Persengiev SP (2009) MicroRNA-mediated gene silencing modulates the UV-induced DNA-damage response. EMBO J 28:2090\u20132099","journal-title":"EMBO J"},{"key":"9_CR91","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.molonc.2013.12.011","volume":"8","author":"MT Jaarsveld van","year":"2014","unstructured":"van Jaarsveld MT, Wouters MD, Boersma AW, Smid M, van Ijcken WF, Mathijssen RH, Hoeijmakers JH, Martens JW, van Laere S, Wiemer EA, Pothof J (2014) DNA damage responsive microRNAs misexpressed in human cancer modulate therapy sensitivity. Mol Oncol 8:458\u2013468","journal-title":"Mol Oncol"},{"key":"9_CR92","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.tcb.2013.09.008","volume":"24","author":"F d'Adda di Fagagna","year":"2014","unstructured":"d'Adda di Fagagna F (2014) A direct role for small non-coding RNAs in DNA damage response. Trends Cell Biol 24:171\u2013178","journal-title":"Trends Cell Biol"},{"key":"9_CR93","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/nrm3523","volume":"14","author":"D Chowdhury","year":"2013","unstructured":"Chowdhury D, Choi YE, Brault ME (2013) Charity begins at home: non-coding RNA functions in DNA repair. Nat Rev Mol Cell Biol 14:181\u2013189","journal-title":"Nat Rev Mol Cell Biol"},{"key":"9_CR94","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1517\/14712598.2014.950650","volume":"14","author":"G Bottai","year":"2014","unstructured":"Bottai G, Pasculli B, Calin GA, Santarpia L (2014) Targeting the microRNA-regulating DNA damage\/repair pathways in cancer. Expert Opin Biol Ther 14:1667\u20131683","journal-title":"Expert Opin Biol Ther"},{"key":"9_CR95","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.mrfmmm.2011.03.012","volume":"717","author":"MD Wouters","year":"2011","unstructured":"Wouters MD, van Gent DC, Hoeijmakers JHJ, Pothof J (2011) MicroRNAs, the DNA damage response and cancer. Mutat Res 717:54\u201366","journal-title":"Mutat Res"},{"key":"9_CR96","doi-asserted-by":"publisher","first-page":"11111","DOI":"10.1158\/0008-5472.CAN-07-2858","volume":"67","author":"JB Weidhaas","year":"2007","unstructured":"Weidhaas JB, Babar I, Nallur SM, Trang P, Roush S, Boehm M, Gillespie E, Slack FJ (2007) MicroRNAs as potential agents to alter resistance to cytotoxic anticancer therapy. Cancer Res 67:11111\u201311116","journal-title":"Cancer Res"},{"key":"9_CR97","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1158\/1535-7163.MCT-07-0573","volume":"7","author":"PE Blower","year":"2008","unstructured":"Blower PE, Chung JH, Verducci JS, Lin S, Park JK, Dai Z, Liu CG, Schmittgen TD, Reinhold WC, Croce CM, Weinstein JN, Sadee W (2008) MicroRNAs modulate the chemosensitivity of tumor cells. Mol Cancer Ther 7:1\u20139","journal-title":"Mol Cancer Ther"},{"key":"9_CR98","doi-asserted-by":"publisher","first-page":"427","DOI":"10.3109\/01902148.2011.584263","volume":"37","author":"Q Wang","year":"2011","unstructured":"Wang Q, Zhong M, Liu W, Li J, Huang J, Zheng L (2011) Alterations of microRNAs in cisplatin-resistant human non-small cell lung cancer cells (A549\/DDP). Exp Lung Res 37:427\u2013434","journal-title":"Exp Lung Res"},{"key":"9_CR99","doi-asserted-by":"publisher","first-page":"21098","DOI":"10.1073\/pnas.1015541107","volume":"107","author":"N Valeri","year":"2010","unstructured":"Valeri N, Gasparini P, Braconi C, Paone A, Lovat F, Fabbri M, Sumani KM, Alder H, Amadori D, Patel T, Nuovo GJ, Fishel R, Croce CM (2010) MicroRNA-21 induces resistance to 5-fluorouracil by down-regulating human DNA MutS homolog 2 (hMSH2). Proc Natl Acad Sci 107:21098\u201321103","journal-title":"Proc Natl Acad Sci"},{"key":"9_CR100","doi-asserted-by":"publisher","first-page":"4037","DOI":"10.1158\/0008-5472.CAN-12-0103","volume":"72","author":"Y Wang","year":"2012","unstructured":"Wang Y, Huang JW, Calses P, Kemp CJ, Taniguchi T (2012) MiR-96 downregulates REV1 and RAD51 to promote cellular sensitivity to cisplatin and PARP inhibition. Cancer Res 72:4037\u20134046","journal-title":"Cancer Res"},{"key":"9_CR101","doi-asserted-by":"publisher","first-page":"4536","DOI":"10.1073\/pnas.1402604111","volume":"111","author":"P Gasparini","year":"2014","unstructured":"Gasparini P, Lovat F, Fassan M, Casadei L, Cascione L, Jacob NK, Carasi S, Palmieri D, Costinean S, Shapiro CL, Huebner K, Croce CM (2014) Protective role of miR-155 in breast cancer through RAD51 targeting impairs homologous recombination after irradiation. Proc Natl Acad Sci U S A 111:4536\u20134541","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9_CR102","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1111\/febs.13150","volume":"282","author":"KI Savage","year":"2015","unstructured":"Savage KI, Harkin DP (2015) BRCA1, a \u2018complex\u2019 protein involved in the maintenance of genomic stability. FEBS J 282:630\u2013646","journal-title":"FEBS J"},{"key":"9_CR103","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.molcel.2010.12.005","volume":"41","author":"P Moskwa","year":"2011","unstructured":"Moskwa P, Buffa FM, Pan Y, Panchakshari R, Gottipati P, Muschel RJ, Beech J, Kulshrestha R, Abdelmohsen K, Weinstock DM, Gorospe M, Harris AL, Helleday T, Chowdhury D (2011) miR-182-mediated downregulation of BRCA1 impacts DNA repair and sensitivity to PARP inhibitors. Mol Cell 41:210\u2013220","journal-title":"Mol Cell"},{"key":"9_CR104","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1002\/emmm.201100136","volume":"3","author":"AI Garcia","year":"2011","unstructured":"Garcia AI, Buisson M, Bertrand P, Rimokh R, Rouleau E, Lopez BS, Lidereau R, Mikaelian I, Mazoyer S (2011) Down-regulation of BRCA1 expression by miR-146a and miR-146b-5p in triple negative sporadic breast cancers. EMBO Mol Med 3:279\u2013290","journal-title":"EMBO Mol Med"},{"key":"9_CR105","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.pharmthera.2015.01.004","volume":"150","author":"L Li","year":"2015","unstructured":"Li L, Li W (2015) Epithelial-mesenchymal transition in human cancer: comprehensive reprogramming of metabolism, epigenetics, and differentiation. Pharmacol Ther 150:33\u201346","journal-title":"Pharmacol Ther"},{"key":"9_CR106","first-page":"9","volume":"7","author":"HA Zielinska","year":"2015","unstructured":"Zielinska HA, Bahl A, Holly JM, Perks CM (2015) Epithelial-to-mesenchymal transition in breast cancer: a role for insulin-like growth factor I and insulin-like growth factor-binding protein 3? Breast Cancer (Dove Med Press) 7:9\u201319","journal-title":"Breast Cancer (Dove Med Press)"},{"key":"9_CR107","doi-asserted-by":"publisher","first-page":"358","DOI":"10.3389\/fonc.2014.00358","volume":"4","author":"S Lindsey","year":"2014","unstructured":"Lindsey S, Langhans SA (2014) Crosstalk of oncogenic signaling pathways during epithelial-mesenchymal transition. Front Oncol 4:358","journal-title":"Front Oncol"},{"key":"9_CR108","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.3892\/mmr.2013.1403","volume":"7","author":"Y Chen","year":"2013","unstructured":"Chen Y, Sun Y, Chen L, Xu X, Zhang X, Wang B, Min L, Liu W (2013) miRNA-200c increases the sensitivity of breast cancer cells to doxorubicin through the suppression of E-cadherin-mediated PTEN\/Akt signaling. Mol Med Rep 7:1579\u20131584","journal-title":"Mol Med Rep"},{"key":"9_CR109","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0062334","volume":"8","author":"TT Manavalan","year":"2013","unstructured":"Manavalan TT, Teng Y, Litchfield LM, Muluhngwi P, Al-Rayyan N, Klinge CM (2013) Reduced expression of miR-200 family members contributes to antiestrogen resistance in LY2 human breast cancer cells. PLoS One 8, e62334","journal-title":"PLoS One"},{"key":"9_CR110","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1002\/ijc.28782","volume":"135","author":"WD Bai","year":"2014","unstructured":"Bai WD, Ye XM, Zhang MY, Zhu HY, Xi WJ, Huang X, Zhao J, Gu B, Zheng GX, Yang AG, Jia LT (2014) MiR-200c suppresses TGF-beta signaling and counteracts trastuzumab resistance and metastasis by targeting ZNF217 and ZEB1 in breast cancer. Int J Cancer 135:1356\u20131368","journal-title":"Int J Cancer"},{"key":"9_CR111","doi-asserted-by":"publisher","first-page":"3995","DOI":"10.1158\/0008-5472.CAN-14-0110","volume":"74","author":"E Izumchenko","year":"2014","unstructured":"Izumchenko E, Chang X, Michailidi C, Kagohara L, Ravi R, Paz K, Brait M, Hoque M, Ling S, Bedi A, Sidransky D (2014) The TGFbeta-miR200-MIG6 pathway orchestrates the EMT-associated kinase switch that induces resistance to EGFR inhibitors. Cancer Res 74:3995\u20134005","journal-title":"Cancer Res"},{"key":"9_CR112","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1158\/1535-7163.MCT-13-0448","volume":"13","author":"K Kitamura","year":"2014","unstructured":"Kitamura K, Seike M, Okano T, Matsuda K, Miyanaga A, Mizutani H, Noro R, Minegishi Y, Kubota K, Gemma A (2014) MiR-134\/487b\/655 cluster regulates TGF-beta-induced epithelial-mesenchymal transition and drug resistance to gefitinib by targeting MAGI2 in lung adenocarcinoma cells. Mol Cancer Ther 13:444\u2013453","journal-title":"Mol Cancer Ther"},{"key":"9_CR113","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0084597","volume":"9","author":"CG Lee","year":"2014","unstructured":"Lee CG, McCarthy S, Gruidl M, Timme C, Yeatman TJ (2014) MicroRNA-147 induces a mesenchymal-to-epithelial transition (MET) and reverses EGFR inhibitor resistance. PLoS One 9, e84597","journal-title":"PLoS One"},{"key":"9_CR114","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1016\/j.febslet.2014.04.024","volume":"588","author":"L Jiang","year":"2014","unstructured":"Jiang L, He D, Yang D, Chen Z, Pan Q, Mao A, Cai Y, Li X, Xing H, Shi M, Chen Y, Bruce IC, Wang T, Jin L, Qi X, Hua D, Jin J, Ma X (2014) MiR-489 regulates chemoresistance in breast cancer via epithelial mesenchymal transition pathway. FEBS Lett 588:2009\u20132015","journal-title":"FEBS Lett"},{"key":"9_CR115","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.18632\/oncotarget.2714","volume":"6","author":"J Ma","year":"2015","unstructured":"Ma J, Fang B, Zeng F, Ma C, Pang H, Cheng L, Shi Y, Wang H, Yin B, Xia J, Wang Z (2015) Down-regulation of miR-223 reverses epithelial-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells. Oncotarget 6:1740\u20131749","journal-title":"Oncotarget"},{"key":"9_CR116","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nrc3184","volume":"12","author":"LV Nguyen","year":"2012","unstructured":"Nguyen LV, Vanner R, Dirks P, Eaves CJ (2012) Cancer stem cells: an evolving concept. Nat Rev Cancer 12:133\u2013143","journal-title":"Nat Rev Cancer"},{"key":"9_CR117","doi-asserted-by":"publisher","first-page":"3091","DOI":"10.1038\/onc.2013.269","volume":"33","author":"DH Wiseman","year":"2014","unstructured":"Wiseman DH, Greystoke BF, Somervaille TC (2014) The variety of leukemic stem cells in myeloid malignancy. Oncogene 33:3091\u20133098","journal-title":"Oncogene"},{"key":"9_CR118","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/nrd4253","volume":"13","author":"DR Pattabiraman","year":"2014","unstructured":"Pattabiraman DR, Weinberg RA (2014) Tackling the cancer stem cells \u2013 what challenges do they pose? Nat Rev Drug Discov 13:497\u2013512","journal-title":"Nat Rev Drug Discov"},{"key":"9_CR119","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1158\/0008-5472.CAN-06-2030","volume":"67","author":"C Li","year":"2007","unstructured":"Li C, Heidt DG, Dalerba P, Burant CF, Zhang L, Adsay V, Wicha M, Clarke MF, Simeone DM (2007) Identification of pancreatic cancer stem cells. Cancer Res 67:1030\u20131037","journal-title":"Cancer Res"},{"key":"9_CR120","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/nature05372","volume":"445","author":"CA O'Brien","year":"2007","unstructured":"O'Brien CA, Pollett A, Gallinger S, Dick JE (2007) A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 445:106\u2013110","journal-title":"Nature"},{"key":"9_CR121","doi-asserted-by":"publisher","first-page":"3983","DOI":"10.1073\/pnas.0530291100","volume":"100","author":"M Al-Hajj","year":"2003","unstructured":"Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF (2003) Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A 100:3983\u20133988","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9_CR122","first-page":"5821","volume":"63","author":"SK Singh","year":"2003","unstructured":"Singh SK, Clarke ID, Terasaki M, Bonn VE, Hawkins C, Squire J, Dirks PB (2003) Identification of a cancer stem cell in human brain tumors. Cancer Res 63:5821\u20135828","journal-title":"Cancer Res"},{"key":"9_CR123","doi-asserted-by":"publisher","first-page":"3743","DOI":"10.4161\/cc.27305","volume":"12","author":"A Antoniou","year":"2013","unstructured":"Antoniou A, Hebrant A, Dom G, Dumont JE, Maenhaut C (2013) Cancer stem cells, a fuzzy evolving concept: a cell population or a cell property? Cell Cycle 12:3743\u20133748","journal-title":"Cell Cycle"},{"key":"9_CR124","doi-asserted-by":"publisher","first-page":"5950","DOI":"10.1158\/0008-5472.CAN-11-1035","volume":"71","author":"C Liu","year":"2011","unstructured":"Liu C, Tang DG (2011) MicroRNA regulation of cancer stem cells. Cancer Res 71:5950\u20135954","journal-title":"Cancer Res"},{"key":"9_CR125","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.cell.2009.07.011","volume":"138","author":"Y Shimono","year":"2009","unstructured":"Shimono Y, Zabala M, Cho R, Lobo N, Dalerba P, Qian D, Diehn M, Liu H, Panula S, Chiao E (2009) Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells. Cell 138:592\u2013603","journal-title":"Cell"},{"key":"9_CR126","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0006816","volume":"4","author":"Q Ji","year":"2009","unstructured":"Ji Q, Hao X, Zhang M, Tang W, Yang M, Li L, Xiang D, Desano JT, Bommer GT, Fan D, Fearon ER, Lawrence TS, Xu L (2009) MicroRNA miR-34 inhibits human pancreatic cancer tumor-initiating cells. PLoS One 4, e6816","journal-title":"PLoS One"},{"key":"9_CR127","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s00109-014-1129-2","volume":"92","author":"U Raza","year":"2014","unstructured":"Raza U, Zhang JD, Sahin O (2014) MicroRNAs: master regulators of drug resistance, stemness, and metastasis. J Mol Med (Berl) 92:321\u2013336","journal-title":"J Mol Med (Berl)"},{"key":"9_CR128","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.oraloncology.2010.12.001","volume":"47","author":"CC Yu","year":"2011","unstructured":"Yu CC, Chen YW, Chiou GY, Tsai LL, Huang PI, Chang CY, Tseng LM, Chiou SH, Yen SH, Chou MY, Chu PY, Lo WL (2011) MicroRNA let-7a represses chemoresistance and tumourigenicity in head and neck cancer via stem-like properties ablation. Oral Oncol 47:202\u2013210","journal-title":"Oral Oncol"},{"key":"9_CR129","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1016\/j.biomaterials.2011.10.071","volume":"33","author":"YP Yang","year":"2012","unstructured":"Yang YP, Chien Y, Chiou GY, Cherng JY, Wang ML, Lo WL, Chang YL, Huang PI, Chen YW, Shih YH, Chen MT, Chiou SH (2012) Inhibition of cancer stem cell-like properties and reduced chemoradioresistance of glioblastoma using microRNA145 with cationic polyurethane-short branch PEI. Biomaterials 33:1462\u20131476","journal-title":"Biomaterials"},{"key":"9_CR130","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/j.stem.2010.11.010","volume":"7","author":"S Ma","year":"2010","unstructured":"Ma S, Tang KH, Chan YP, Lee TK, Kwan PS, Castilho A, Ng I, Man K, Wong N, To KF, Zheng BJ, Lai PB, Lo CM, Chan KW, Guan XY (2010) miR-130b Promotes CD133(+) liver tumor-initiating cell growth and self-renewal via tumor protein 53-induced nuclear protein 1. Cell Stem Cell 7:694\u2013707","journal-title":"Cell Stem Cell"},{"key":"9_CR131","doi-asserted-by":"publisher","first-page":"34970","DOI":"10.1074\/jbc.M112.374611","volume":"287","author":"CX Xu","year":"2012","unstructured":"Xu CX, Xu M, Tan L, Yang H, Permuth-Wey J, Kruk PA, Wenham RM, Nicosia SV, Lancaster JM, Sellers TA, Cheng JQ (2012) MicroRNA miR-214 regulates ovarian cancer cell stemness by targeting p53\/Nanog. J Biol Chem 287:34970\u201334978","journal-title":"J Biol Chem"},{"key":"9_CR132","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1002\/stem.741","volume":"29","author":"N Bitarte","year":"2011","unstructured":"Bitarte N, Bandres E, Boni V, Zarate R, Rodriguez J, Gonzalez-Huarriz M, Lopez I, Javier Sola J, Alonso MM, Fortes P, Garcia-Foncillas J (2011) MicroRNA-451 is involved in the self-renewal, tumorigenicity, and chemoresistance of colorectal cancer stem cells. Stem Cells 29:1661\u20131671","journal-title":"Stem Cells"},{"key":"9_CR133","doi-asserted-by":"publisher","first-page":"32800","DOI":"10.1074\/jbc.M111.308528","volume":"287","author":"LY Bourguignon","year":"2012","unstructured":"Bourguignon LY, Wong G, Earle C, Chen L (2012) Hyaluronan-CD44v3 interaction with Oct4-Sox2-Nanog promotes miR-302 expression leading to self-renewal, clonal formation, and cisplatin resistance in cancer stem cells from head and neck squamous cell carcinoma. J Biol Chem 287:32800\u201332824","journal-title":"J Biol Chem"}],"container-title":["Methods in Molecular Biology","Cancer Drug Resistance"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4939-3347-1_9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,5]],"date-time":"2022-06-05T01:01:33Z","timestamp":1654390893000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4939-3347-1_9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"ISBN":["9781493933457","9781493933471"],"references-count":133,"URL":"https:\/\/doi.org\/10.1007\/978-1-4939-3347-1_9","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}